Live Breaking News & Updates on Treatment collaborative network

Stay informed with the latest breaking news from Treatment collaborative network on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Treatment collaborative network and stay connected to the pulse of your community

Chinese diagnostics firm WuXi Diagnostics raises $150m in Series B round

Chinese diagnostics firm WuXi Diagnostics raises $150m in Series B round
WuXi Diagnostics has developed a series of COVID-19 detection products. Source: WuXi Diagnostics
February 24, 2021
Chinese integrated diagnostics developer WuXi Diagnostics has raised $150 million in a Series B round of financing to advance its R&D pipeline and open-access innovation enabling platform, as the firm seeks to accelerate its market penetration in the global diagnostics sector.
The Series B round was backed by new investors including Thermo Fisher Scientific, the world’s largest maker of scientific instruments; healthcare-focused investment firm Shiyu Capital; ABC International, a wholly-owned subsidiary of Agricultural Bank of China; Sunland Capital, which focuses on early- and growth-stage healthcare investments; and equity investment fund CCBI Tech Venture.

China , Shiyu , Hainan , Beijing , Shanghai , United-states , Wuxi , Jiangsu , Suzhou , Chinese , American , Jack-ma